<DOC>
	<DOCNO>NCT00407199</DOCNO>
	<brief_summary>This pilot study focus collection preliminary data determine efficacy quetiapine individual social phobia . We hypothesize individual react less self-reported anxiety physiological reactivity drug condition placebo condition . If true , would constitute strong signal significant treatment effect quetiapine social phobia . A positive treatment effect study would provide rationale investigation efficacy quetiapine cue reactivity individual social phobia . Further study would include increased sample size order obtain statistical power replication finding . We utilize IR formulation quetiapine .</brief_summary>
	<brief_title>The Use Quetiapine ( Seroquel ) Treatment Social Phobia : Public Speaking Environment</brief_title>
	<detailed_description>Primary Objective : The purpose study evaluate use quetiapine diminish cue reactivity Virtual Reality environment individual Social Phobia . The following primary secondary outcome measure administer subject Virtual Reality exposure treatment non-treatment condition . The outcome measure demonstrate adequate reliability validity detection clinical change individual social phobia open label study use quetiapine ( Schutters , van Megen , Westenberg , 2005 ) . The Personal Report Confidence Speaker ( PRCS ; Paul , 1966 ) utilize primary measure establish individual diagnosis severity level . Pertaub Slater ( 2002 ) demonstrate sensitivity PRCS measure anxiety response virtual audience . A total score 21 great PRCS require study inclusion ( Carrigan Levis , 1999 ) . Carrigan Lewis ( 1999 ) report mean score 23.73 30-item PRCS individual report fear public speaking . Subjective unit distress rating measure blood pressure heart rate obtain within session order measure immediate change subject 's cue reactivity VRE stimulus . The outcome measure include : Primary Measure : Personal Report Confidence Speaker ( PRCS ) Secondary Measures : Liebowitz Social Anxiety Scale ( LSAS ) Clinical Global Impressions-Improvement Scale ( CGI ) Brief Social Phobia Scale Social Phobia Inventory Fear Negative Evaluation Scale Hamilton Rating Scale Anxiety In session-Subjective Units Distress Blood Pressure heart rate monitor within session Design : A crossover , double-blind within subject design use . The two condition placebo drug prior exposure social anxiety cue virtual environment . Each subject condition course two visit . Each subject one condition first visit cross-over condition second visit . Order counter-balanced across subject . The treatment phase study include two afore mention visit , total 60 minute . This include treatment pre-post assessment</detailed_description>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Age 1825 Primary DSMIV Axis I diagnosis social phobia , specific fear public speaking PRCS total score : 21 great ( 1 SD population norm 14.2 ) Current contraindications/sensitivity quetiapine Current prescription benzodiazepine , tranquilizer , antipsychotic medication Current Psychotic episode Current Manic episode Current Depressive episode Current drug alcohol dependence A patient diabetes mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrollment glycosylated hemoglobin ( HbA1c ) 8.5 % . Admitted hospital treatment DM DM relate illness within past 12 week Not physician care DM . Physician responsible patient 's DM care indicate patient 's DM control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>social phobia , anxiety , quetiapine</keyword>
</DOC>